Magic mushrooms may help stroke victims relearn movement
NCT ID NCT07053917
Summary
This early-stage study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' is safe for people who had a stroke over a year ago. Researchers believe psilocybin might temporarily reopen a critical learning period in the brain, potentially making physical therapy more effective for regaining movement. The study will monitor 20 participants closely for safety and will also check for early signs of improvement in arm and hand function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.